Figure 2.

Disease activity over time following treatment with new therapeutic agents or nontreatment. Disease activity, as measured by the disease activity score from 28-joint count with three parameters (DAS28-3), over time in patients treated or not treated with new therapeutic agents, 2000 to 2004. LEF, leflunomide.